Ramky Infrastructure Limited has informed the Exchange regarding a press release dated March 13, 2026, titled "Announcement on Execution of Concession Agreement for Development of High-Tech Pharmaceutical Park at Dighi Port Industrial Area, Maharashtra".
RAMKY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ramky Infrastructure's wholly owned subsidiary, Maha Integrated Life Sciences City Limited (MILeS City), has signed a 95-year concession agreement with Maharashtra Industrial Development Corporation (MIDC) to develop a High-Tech Pharmaceutical Park at Dighi Port Industrial Area in Raigad district, Maharashtra. The project, valued at approximately INR 3,000 crore, will be executed on a PPP basis under the DBFOT model, covering around 1,000 hectares with industrial zones, commercial areas, R&D centres, and shared infrastructure for pharma and biotech firms. The construction phase is expected over the next 5 years, after which MILeS City will operate and maintain the project for 90 years, earning revenue from land lease premiums, development charges, maintenance fees, and utility charges. With this addition, Ramky's order book has grown to approximately INR 13,500 crore, reinforcing its pipeline of large-scale infrastructure projects.
This is a major order book win for Ramky Infrastructure, adding INR 3,000 crore to its backlog and providing long-term revenue visibility through a 90-year operating period. The PPP concession structure offers annuity-like cash flows beyond the construction phase, which is positive for long-term shareholder value, though execution risk on a 5-year, 1,000-hectare buildout remains a key factor to watch.